DeepWise Closes its C+ Round

Following the approval of China's innovative AI product NMPA Class III certificate, DeepWise today announced the completion of hundreds of millions of yuan in C+ round financing. This round of financing was led by Zhongguancun Longmen Investment, followed by institutions such as Shanghai New Alliance Investment Management, and old shareholder Legend Capital continued to invest in this round. This is the fifth round of financing since the company was founded four years ago.

Founded in 2017, DeepWise is headquartered in the high-tech core area of Zhongguancun, Beijing. The company uses AI technology and self-developed core algorithms to provide various medical service organizations with AI and Internet-based medical solutions. DeepWise currently has independent operating companies in Beijing, Hangzhou and Shanghai.

In addition, DeepWise has gathered professionals in many fields such as artificial intelligence, Internet cloud computing, and medical imaging to form its core department "Shen Rui Research Institute". DeepWise Research Institute focuses on the exploration of cutting-edge medical science and technology, and is responsible for the algorithm research and development of the company's core products. It has published academic papers with a cumulative impact factor of nearly 170, and has obtained and is accepting nearly 150 patents and soft works.

DeepWise is also currently undertaking a number of major special scientific research projects from the Ministry of Science and Technology, National Natural Science and major cities across the country, and in-depth cooperation with relevant national departments, major university scientific research teams and top domestic medical institutions, and is making every effort to promote rapid clinical application of scientific research results Conversion.

Based on the application scenarios of smart medical care, DeepWise is building a rich AI-based smart imaging product matrix, hoping to provide services covering the entire clinical diagnosis process. At present, DeepWise's business includes: fully closed-loop AI smart services from intelligent diagnosis guidance, consultation appointments to follow-up management, from medical imaging to multi-modal AI covering various high-dimensional data such as images, texts, inspections, pathology, genes, etc. Special disease data platform, multi-modal intelligent scientific research from basic statistics to machine learning and deep learning.

According to reports, DeepWise's AI smart imaging products have been used in more than 400 hospitals.